Better Buy: Inovio Pharmaceuticals, Inc. vs. Novavax, Inc.
As of now, 2017 is turning out to be a bust for shareholders of both Inovio Pharmaceuticals (NASDAQ: INO) and Novavax (NASDAQ: NVAX). However, both clinical-stage biotech stocks were looking pretty good earlier in the year. Inovio's slump came following a stock offering, while Novavax stock sank on investors' disappointment with a clinical update from the company.
With Inovio and Novavax shares down significantly so far this year, which stock is now the better buy? Here's how the two biotechs compare.
Image source: Getty Images.
Source: Fool.com
